FRAF:NASDAQFranklin Financial Services Corporation Analysis
Data as of 2026-04-04 - not real-time
$51.67
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Franklin Financial Services (FRAF) is trading around $51.7, just below its near‑term resistance of $52 and above the $47 support level. The 20‑day SMA (≈$49.8) sits below price, the MACD histogram is positive and the signal line is bullish, while RSI at ~57 suggests neither overbought nor oversold conditions; volume is on an upward trend, reinforcing the neutral‑to‑slightly‑bullish technical backdrop.
Fundamentally, the bank posted a striking 54.7% revenue growth year‑over‑year, trades at a forward PE of ~8.2 versus an industry average of 16.6, and offers a 2.56% dividend yield with a modest payout ratio (~27%). The DCF‑derived fair value of roughly $126 implies an upside of ~14% from current levels, and a low beta (~0.48) points to limited market sensitivity. Together, these metrics paint a picture of a potentially undervalued, growth‑oriented regional bank with solid cash generation and sustainable dividends.
Fundamentally, the bank posted a striking 54.7% revenue growth year‑over‑year, trades at a forward PE of ~8.2 versus an industry average of 16.6, and offers a 2.56% dividend yield with a modest payout ratio (~27%). The DCF‑derived fair value of roughly $126 implies an upside of ~14% from current levels, and a low beta (~0.48) points to limited market sensitivity. Together, these metrics paint a picture of a potentially undervalued, growth‑oriented regional bank with solid cash generation and sustainable dividends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate resistance with bullish MACD support
- Increasing volume indicating buying interest
- RSI in neutral range, limiting upside risk
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~14% upside
- Strong revenue growth and low relative PE
- Sustainable dividend yield enhancing total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Fundamental undervaluation versus industry peers
- Low beta and stable earnings profile
- Long‑term growth prospects from expanding loan portfolio and non‑bank investments
Key Metrics & Analysis
Financial Health
Revenue Growth54.70%
Profit Margin24.70%
P/E Ratio10.9
ROE13.27%
ROA0.96%
P/B Ratio1.3
Op. Cash Flow$25.4M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI56.9
Support$47.00
Resistance$52.02
MA 20$49.84
MA 50$50.13
MA 200$46.96
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$126.32
Target Price$59.00
Upside/Downside14.19%
GradeUndervalued
TypeBlend
Dividend Yield2.56%
Risk Assessment
Beta0.48
Volatility26.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.